NKG2D CAR-T cells with CD27 or 4-1BB costimulatory signaling molecules could promote the expansion and self-enrichment of CAR-T cells without the presence of IL-2, effectively enhancing the ability to recognize and eliminate breast cancer (30). This evidence concerns the gene CD27 and breast carcinoma.